Source: iQoncept / Shutterstock
Lyra Therapeutics (NASDAQ:LYRA) just reported results for the first quarter of 2024.
- Lyra Therapeutics reported earnings per share of -35 cents. This was below the analyst estimate for EPS of -26 cents.
- The company reported revenue of $532,000.
- This was 26.67% better than the analyst estimate for revenue of $420,000.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/04/lyra-stock-earnings-lyra-therapeutics-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC